MARCH 20 MEDICINES CATALOG · GLOBAL DRUG FACILITY MEDICINES CATALOG JANUARY 2020 As a unit of the...
Transcript of MARCH 20 MEDICINES CATALOG · GLOBAL DRUG FACILITY MEDICINES CATALOG JANUARY 2020 As a unit of the...
Ensuring an uninterrupted supply of quality-assured, affordable tuberculosis (TB) medicines and diagnostics to the world. stoptb.org/gdf
GLOBAL DRUG FACILITY (GDF)
MARCH 2020 MEDICINES CATALOG
Stop TB Partnership | Global Drug FacilityGlobal Health Campus – Chemin du Pommier 401218 Le Grand-Saconnex | Geneva, SwitzerlandEmail: [email protected]
Last verion's date: 30 March 2020Stop TB Partnership/Global Drug Facility licensed this product under an Attribution-NonCommercial-NoDerivatives 4.0 International License. (CC BY-NC-ND 4.0) https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode
GLOBAL DRUG FACILITYMEDICINES CATALOG JANUARY 2020As a unit of the Stop TB Partnership, GDF provides a range of quality-assured medicines and medical supplies to treat all forms of TB in adults, adolescents and children. This catalog is categorized by products used to treat adults and adolescents as well as children. Each section is subdivided into single medicines and fixed-dose combinations, in alphabetical order by the description. Each product is marked for its intended use, as recommended by WHO, i.e. to treat drug-sensitive TB, drug-resistant TB and/or latent TB infections.
To place an order for any medicine or medical supply, please follow the step-by-step guide available on the GDF website. All prices in this catalogue are listed as ex-works (EXW) prices.
stoptb.org/gdf
TABLE OF CONTENTSADULT & ADOLESCENT FORMULATIONS
SINGLE MEDICINES
FIXED-DOSE COMBINATIONS
03
06
CHILD-FRIENDLY FORMULATIONS
SINGLE MEDICINES
FIXED-DOSE COMBINATIONS
07
08
MEDICAL SUPPLIES 09
MEDICINES CATALOG 2
ADULT & ADOLESCENT FORMULATIONSThese formulations are indicated for the treatment of all kinds of TB in adults and adolescents.
SINGLE MEDICINES
* Price ranges shown are the lowest and highest available. Actual prices within the indicated rangewill be based on order volume, requested delivery time and country regulatory requirements.For budgetary purposes, countries are encouraged to use the highest price available.** To be used with imipenem/cilastatin or meropenem only
STOP TB PARTNERSHIP GLOBAL DRUG FACILITY 3
AD
ULT
& A
DO
LES
CE
NT
FOR
MU
LA
TIO
NS
PRODUCT CODE
DESCRIPTION (MEDICINE, STRENGTH, FORMULA-TION, PACKAGING)
NUMBER OF UNITS PER PACK
PRICE OR PRICE RANGE
(USD)
Am-500-(A)-10 Amikacin, 500 mg/2 ml, Solution for injection, Ampoule(s)
10 6.21-6.834
Amx/Clv-500/125-(B)-100
Amoxicillin/Clavulanic acid, 500 mg/125 mg, Film coated tablet(s), Blister(s)
100 12.394 **
Amx/Clv-875/125-(B)-100
Amoxicillin/Clavulanic acid, 875 mg/125 mg, Film coated tablet(s), Blister(s)
100 11.804 **
Bdq-100-(L)-188 Bedaquiline, 100 mg, Uncoated tablet(s), HDPE container(s)
188 400.004
Cm-0.5-(V)-1 Capreomycin 0.5 g, Powder, for injection, Vial(s)
1 Please contact GDF
Cm-1-(V)-10 Capreomycin, 1 g, Powder,for injection, Vial(s)
10 Please contact GDF
Cfz-100-(L)-100 Clofazimine, 100 mg, Capsule(s), HDPE jar(s)
100 50.00-90.004
Cfz-50-(L)-100 Clofazimine, 50 mg, Capsule(s), HDPE jar(s)
100 35.784
Cs-250-(B)-100 Cycloserine, 250 mg, Capsule(s), Blister(s)
100 24.00-26.304
Dlm-50-(B)-672 Delamanid, 50 mg, Film coated tablet(s), Blister(s)
672 1700.004
* DRUG-
SENSITIVE TB
DRUG-
RESISTANT TB
LATENT
TB INFE
CTION
SINGLE MEDICINES
STOP TB PARTNERSHIP GLOBAL DRUG FACILITY4
AD
ULT
& A
DO
LES
CE
NT
FOR
MU
LA
TIO
NS
PRODUCT CODE
DESCRIPTION (MEDICINE, STRENGTH, FORMULA-TION, PACKAGING)
NUMBER OF UNITS PER PACK
PRICE OR PRICE RANGE
(USD)
E-400-(B)-672 Ethambutol, 400 mg, Film coated tablet(s), Blister(s)
672 20.20-25.004 4
Eto-250-(B)-100 Ethionamide, 250 mg, Film coated tablet(s), Blister(s)
100 8.92-10.634
Imp/Cls-500/500-(V)-10
Imipenem/Cilastatin, 500 mg/500 mg, Powder, for injection, Vial(s)
10 30.504
H-300-(B)-672 Isoniazid, 300 mg, Uncoated tablet(s), Blister(s)
672 11.92-13.524 4 4
Km-0.5-(V)-1 Kanamycin, 0.5 g, Powder, for injection, Vial(s)
1 Please contact GDF
Km-1-(V)-50 Kanamycin, 1 g, Powder, for injection, Vial(s)
50 Please contact GDF
Km-1-(A)-10 Kanamycin, 1 g/4 ml, Solution for injection, Ampoule(s)
10 Please contact GDF
Lfx-250-(B)-100 Levofloxacin, 250 mg, Film coated tablet(s), Blister(s)
100 2.65-3.024
Lfx-500-(B)-100 Levofloxacin, 500 mg, Film coated tablet(s), Blister(s)
100 3.96-4.664
Lfx-750-(B)-100 Levofloxacin, 750 mg, Film coated tablet(s), Blister(s)
100 9.904
Lzd-600-(B)-100
Linezolid, 600 mg, Film coated tablet(s), Blister(s)
100 44.20-75.004
Mrp-1-(V)-10 Meropenem, 1 g, Powder, for injection, Vial(s)
10 34.254
Mfx-400-(B)-100
Moxifloxacin, 400 mg, Film coated tablet(s), Blister(s)
100 16.90-25.004
Pa-200-(L)-26 Pretomanid, 200 mg, Tablet(s), Bottle
26 52.004
PAS-(H)-4-(S)-30
PAS Acid, 4 g, Granule(s), Sachet
30 40.004
PAS-(Na)-4-(S)-25
PAS Sodium Salt, 4 g, Granule(s), Sachet
25 33.004
DRUG-
SENSITIVE TB
DRUG-
RESISTANT TB
LATENT
TB INFE
CTION
SINGLE MEDICINES
STOP TB PARTNERSHIP GLOBAL DRUG FACILITY 5
AD
ULT
& A
DO
LES
CE
NT
FOR
MU
LA
TIO
NS
PRODUCT CODE
DESCRIPTION (MEDICINE, STRENGTH, FORMULA-TION, PACKAGING)
NUMBER OF UNITS PER PACK
PRICE OR PRICE RANGE
(USD)
Pto-250-(B)-100 Prothionamide, 250 mg, Film coated tablet(s), Blister(s)
100 8.74-12.004
Z-400-(B)-672 Pyrazinamide, 400 mg, Uncoated tablet(s), Blister(s)
672 14.00-14.184 4
Z-500-(B)-672 Pyrazinamide, 500 mg, Uncoated tablet(s), Blister(s)
672 12.91-14.004 4
Pyr(B6)-100-(L)-250
Pyridoxine, 100 mg, Uncoated tablet(s), HDPE jar(s)
250 11.554 4 4
Pyr(B6)-50-(B)-50
Pyridoxine, 50 mg, Film coated tablet(s), Blister(s)
50 0.704 4 4
Rbt-150-(L) -100 Rifabutin, 150 mg, Capsule(s), HDPE jar(s)
100 94.534
R-150-(B)-100 Rifampicin, 150 mg, Film coated tablet(s), Blister(s)
100 6.334 4
R-300-(B)-100 Rifampicin, 300 mg, Film coated tablet(s), Blister(s)
100 10.004 4
Rpt-150-(B)-24 Rifapentine, 150 mg, Film coated tablet(s), Blister(s)
24 15.004
S-1-(V)-10 Streptomycin, 1 g, Powder, for injection, Vial(s)
10 5.414
Trd- 250- (B)-100
Terizidone, 250 mg, Capsule(s), Blister(s)
100 175.004
DRUG-
SENSITIVE TB
DRUG-
RESISTANT TB
LATENT
TB INFE
CTION
*
* Discount price of 5.25 USD per pack may apply to eligible countries for limited time.Please contact your GDF Country Supply Officer or write to [email protected] for further information.
FIXED-DOSE COMBINATIONS
STOP TB PARTNERSHIP GLOBAL DRUG FACILITY6
AD
ULT
& A
DO
LES
CE
NT
FOR
MU
LA
TIO
NS
PRODUCT CODE
DESCRIPTION MEDICINE, STRENGTH, FORMULA-TION, PACKAGING)
NUMBER OF UNITS PER PACK
PRICE OR PRICE RANGE
(USD)
PK-Cat I & III-A Cat I & III Kit A, Film coated tablet(s), Blister(s)
1 26.62-26.894
HPST-Q-TIB-(L)-30
Isoniazid/Pyridoxine hydrochl/Sulfamethoxazole/Trimethoprim,300 mg/ 25 mg/800 mg/160 mg, Uncoated tablet(s), HDPE container(s)
30 1.99
4
2-FDC/RH-150/75-(B)-336
Rifampicin/Isoniazid, 150 mg/75 mg, Film coated tablet(s), Blister(s)
336 13.634
2-FDC/RH-150/75-(B)-672
Rifampicin/Isoniazid, 150 mg/75 mg, Film coated tablet(s), Blister(s)
672 20.69-25.934
3-FDC/RHE-150/75/275-(B)-672
Rifampicin/Isoniazid/Ethambutol, 150 mg/75 mg/275 mg, Film coated tablet(s), Blister(s)
672 37.69-42.46
4
4-FDC/RHZE-150/75/400/275-(B)-336
Rifampicin/Isoniazid/Pyrazinamide/Ethambutol, 150 mg/75 mg/400 mg/ 275 mg, Film coated tablet(s), Blister(s)
336 27.29
4
4-FDC/RHZE-150/75/400/275-(B)-672
Rifampicin/Isoniazid/Pyrazinamide/Ethambutol, 150 mg/75 mg/400 mg/ 275 mg, Film coated tablet(s), Blister(s)
672 47.87-52.75
4
DRUG-
SENSITIVE TB
DRUG-
RESISTANT TB
LATENT
TB INFE
CTION
3-HP-300/ 300-(B)-36
Rifapentine/Isoniazid 300mg/300mg, Film coated tablet(s), Blister(s)
36 15.004
CHILD-FRIENDLY FORMULATIONSThese formulations make it easier for care-givers to give the correct doses and are simpler to administer to children.
SINGLE MEDICINES
* To be used with imipenem/cilastatin or meropenem only.
STOP TB PARTNERSHIP GLOBAL DRUG FACILITY 7
CH
ILD-FR
IEN
DLY
FOR
MU
LA
TIO
NS
PRODUCT CODE
DESCRIPTION (MEDICINE, STRENGTH, FORMULA-TION, PACKAGING)
NUMBER OF UNITS PER PACK
PRICE OR PRICE RANGE
(USD)
Cfz-50-(B)-100 Clofazimine, 50 mg, Tablet(s), Blister(s)
100 49.124
Cs-125-(B)-100 Cycloserine, 125 mg, Capsule(s), Blister(s)
100 454
E-100- (B-DT)-100
Ethambutol, 100 mg, Dispersible tablet(s), Blister(s)
100 22.504 4
E-100-(B)-100 Ethambutol, 100 mg, Film coated tablet(s), Blister(s)
100 3.75-4.304 4
Eto-125-(B-DT)-100
Ethionamide, 125 mg, Dispersible tablet(s), Blister(s)
100 13.004
H-100- (B-DT)-100
Isoniazid, 100 mg, Dispersible tablet(s), Blister(s)
100 9.91-10.004 4 4
H-100-(B)-100 Isoniazid, 100 mg, Uncoated tablet(s), Blister(s)
100 1.03-1.414 4 4
Lfx-100- (B-DT)-100
Levofloxacin, 100 mg, Dispersible tablet(s), Blister(s)
100 12.914
Mfx-100- (B-DT)-100
Moxifloxacin, 100 mg, Dispersible tablet(s), Blister(s)
100 19.904
Z-150-(B-DT)-100 Pyrazinamide, 150 mg, Dispersible tablet(s),
100 9.404 4
DRUG-
SENSITIVE TB
DRUG-
RESISTANT TB
LATENT
TB INFE
CTION
FIXED-DOSE COMBINATIONS
STOP TB PARTNERSHIP GLOBAL DRUG FACILITY8
CH
ILD-FR
IEN
DLY
FOR
MU
LA
TIO
NS
PRODUCT CODE
DESCRIPTION (MEDICINE, STRENGTH, FORMULA-TION, PACKAGING)
NUMBER OF UNITS PER PACK
PRICE OR PRICE RANGE
(USD)
2-FDC/RH-75/50-(B)-84
Rifampicin/Isoniazid, 75 mg/50 mg, Dispersible tablet(s), Strip(s)
84 2.87-3.004 4
3-FDC/RHZ-75/50/150-(B)-84
Rifampicin/Isoniazid/ Pyrazinamide, 75 mg/50mg/150 mg, Dispersible tablet(s), Blister(s)
84 3.60
4
DRUG-
SENSITIVE TB
DRUG-
RESISTANT TB
LATENT
TB INFE
CTION
MEDICAL SUPPLIESGDF facilitates access to medical supplies used in treating TB.
PRODUCT CODE
DESCRIPTION(PRODUCT, PACKAGING)
NUMBER OF UNITS PER PACK
PRICE OR PRICE RANGE
(USD)
S&N - 5 ml/21/22/23 G (RUP/SIP) and Safety Box, 5lt
Auto-disable, reuse-prevention syringes with sharp infury prevention, 5ml, 21/22/23 G, individual sterilized peel-off pack, and Safety Box, 5lt.
100 5.00
4
S&N - 5 ml/21/22/23 G and Safety Box, 5lt
Auto-disable syringes with sharp infury prevention, 5ml, 21/22/23 G, individual sterilized peel-off pack, and Safety Box, 5lt.
100 5.00
4
WFI-5-(V)-50 Water for injections, Solution for injection, Vial(s)
50 4.454
STOP TB PARTNERSHIP GLOBAL DRUG FACILITY 9
ME
DIC
AL S
UP
PLIE
SDRUG-
SENSITIVE TB
DRUG-
RESISTANT TB
LATENT
TB INFE
CTION
Stop TB Partnership | Global Drug FacilityGlobal Health Campus – Chemin du Pommier 401218 Le Grand-Saconnex | Geneva, SwitzerlandEmail: [email protected]